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3ABSTRACT
Objective: To [1] compare the frequency and severity of ultrasound (US) features in
people with normal knees (controls), knee pain (KP), asymptomatic OA (ROA), and
symptomatic OA (SROA), [2] examine relationships between US features, knee pain,
radiographic OA, [3] explore the relationship between change in pain and US
features over a 3-month period.
Method: Community participants were recruited into a multiple group case-control
study. All underwent assessment for pain, knee radiographs and US examination for
effusion, synovial hypertrophy, popliteal cysts and power Doppler (PD) signal within
the synovium. A 3-month follow-up was undertaken in over half of control and SROA
participants.
Results: 243 participants were recruited (90 controls; 59 KP; 32 ROA; 62 SROA).
Effusion and synovial hypertrophy were more common in ROA and SROA
participants. Severity of effusion and synovial hypertrophy were greater in SROA
compared to ROA (p<0.05). Severity of US effusion and synovial hypertrophy were
correlated with radiographic severity (r=0.6 and r=0.7, p<0.01) but the relationship
between pain severity and US features was weak (r=0.3, p<0.01). In SROA
participants, knee pain did not change in tandem with a change in synovial
hypertrophy over time.
Conclusion: US abnormalities are common in OA. Effusion and synovial
hypertrophy were moderately correlated with radiographic severity but the
relationship with pain is less strong. The degree to which these features reflect
“active inflammation” is questionable and they may be better considered as part of
the total organ pathology in OA. Further studies are warranted to confirm these
findings.
4Introduction
Pain is the major stimulus for people with knee osteoarthritis (OA) to seek medical
attention but the causes of pain are complex and radiographs which are the standard
for clinical imaging in OA are often discordant with symptoms1, 2. In recent years
there has been increasing interest in the role of the synovium in painful OA. Although
nowhere as florid or extensive as the inflammation observed in rheumatoid arthritis,
clinical effusions and capsular thickening can be clinically evident in some joints with
knee OA, and are more frequently observed using sensitive measures such as
ultrasound (US) and MRI3-10. Synovial changes in OA are regarded by many as a
secondary response to the degradation of cartilage11 though there are others who
advocate them as a primary driver for OA which may be partly responsible for pain
and disease progression12-16.
Ultrasound (US) allows the direct and indirect evaluation of synovial abnormalities,
namely the presence of grey scale features (effusion, synovial hypertrophy and
bursitis) which are widely considered to be features of inflammation in OA. In
addition the presence of increased power Doppler signal (PDS) within the synovium
is purported to represent more active inflammation17. Synovial abnormalities are
more common in those with painful knee OA compared to those with asymptomatic
OA or normal knees but the association between individual US features and pain is
not conclusive6, 9, 10, 18-20. Indeed, no single US feature has been consistently
associated with knee pain and it has been suggested that the presence of effusion
and synovial hypertrophy may be a marker for structural damage as opposed to
inflammation4, 21. Additionally, most US studies have been conducted in secondary
5care settings and the same may not apply to people with knee OA in primary care
where the vast majority of patients are managed.
The primary aim of this study was to compare the frequency and severity of synovial
abnormalities in people with normal knees, knee pain, radiographic OA and
symptomatic OA from the community. Secondary aims were to examine the
relationships between US features, pain and radiographic severity and to observe
whether temporal change in knee pain over a 3-month period correlated with a
change in US findings.
Methods
A case-control design was used to compare 4 groups: people with normal knees
(controls - without pain and without radiographic OA), knee pain without radiographic
OA (KP), asymptomatic radiographic OA (ROA) and symptomatic ROA (SROA).
Knee pain was classified according to the worst item score on any of the five
WOMAC pain items. Those reporting at least moderate pain were classified as pain
positive and those reporting none or mild pain were classified as pain negative.
Radiographic OA was defined as Kellgren & Lawrence (K/L) grade ≥2 22.
Participants were recruited from previous community studies of knee pain or knee
OA (as either cases or controls) where they had consented to being approached for
future research. The primary source of study participants was a cohort study of
incident knee pain in the community23. Additional participants were recruited from a
randomised controlled trial of non-prescription analgesics for people with chronic
6knee pain24 and a population based case-control study (Genetics of OA and Lifestyle
(GOAL) study25. Participants were purposefully recruited with the aim of attaining fifty
participants in each of the four comparison groups. Sample size was based on a
best estimate from the limited published data for prevalence of knee effusion for
each group 5, 9, 10. Assuming a prevalence of 60% in the SROA group, 30% in the KP
and ROA group and 5% in the control group, 50 participants were required in each
group (200 in total) to detect the minimum difference between groups with 90%
power and <5% type 1 errors. Control and SROA participants were invited to attend
a follow-up US and pain assessment at 3 months.
Participants were excluded if they had a clinical history of inflammatory arthritis,
clinical hip OA, knee joint replacement, knee joint injury or surgery in the previous 3
months, steroid injection to either knee in the previous 3 months, a diagnosis of
Fibromyalgia or chronic widespread pain or severely impaired mobility (Steinbrocker
Grade IV). Participants were asked to refrain from taking any non-steroidal anti-
inflammatory drugs (NSAID) for 48 hours prior to the assessment to allow an
adequate wash-out period; paracetamol could be taken for rescue pain-relief up to
12 hours before.
Study approval was granted by the Derbyshire Research Ethics Committee and all
participants gave written informed consent. All participants underwent a clinical
assessment, US and radiographic evaluation between April 2010 and March 2012.
Assessments
7A range of data was collected including age, gender, body mass index (BMI),
duration of early morning stiffness (EMS) (minutes) and the presence of a moderate
clinical knee effusion. The Western Ontario and McMaster Osteoarthritis Index
(WOMAC) was also used to evaluate knee stiffness and function26.
Pain was assessed using 3 measures, a visual analogue scale (VAS) from 0-100mm
for current knee pain severity, the pain subscale of the WOMAC questionnaire26 and
the Measure of Intermittent and Constant Osteoarthritis Pain questionnaire
(ICOAP)27.
Standardised, weight-bearing, semi-flexed tibio-femoral and skyline 30° patello-
femoral radiographs were scored by a single reader (SD) who was blinded to US
features and pain. Radiographs were scored using the Nottingham logically derived
Line Drawing Atlas (LDA)28, 29. This scoring system uses mathematically calculated
intervals for grading joint space width (JSW) and size of osteophyte for all three
compartments of the knee, to produce an ordinal summated score. Intra-observer
reproducibility for scoring using the LDA has been established as good (kappa =
0.82 (95%, CI 0.78-.089) for JSW and 0.68 (95% CI, 0.63-0.71) for size of
osteophyte)28. An overall Kellgren & Lawrence (K&L) grade (0-4) was also given to
each knee .
Ultrasound assessment
US was performed by a single assessor (MH) on the same day as clinical
assessments using a Toshiba Aplio SSA-770A machine with a multi-frequency (7-12
MHz) linear array transducer. The assessor was blind to the radiographic scores but
not the clinical findings.
8A standardised protocol reflecting current definitions and guidelines was followed5, 30.
Knees were scanned in longitudinal and transverse planes with the joint supported in
30° flexion for ventral and lateral scans and in extension for dorsal scans. The supra-
patellar pouch was scanned widely (including the lateral and medial recesses). The
following features and measurements were recorded:
(1) Effusion: maximal depth was measured in mm and dichotomised as absent if
< 4mm and present if ≥ 4mm5.
(2) Synovial hypertrophy: maximal depth was measured in mm and dichotomised
as absent if < 4mm and present if ≥ 4mm5.
(3) Baker’s cyst: the diameter was measured in the transverse plane and
dichotomised as absent if <4mm or present if > 4mm10.
(4) Bursitis: bursae at the infra-patellar tendon and the insertion of the pes-
anserinus site were measured and dichotomised as absent if <4mm or
present if > 4mm infra-patellar bursae, and absent if <2mm or present if >
2mm for the pes-anserine bursa10.
(5) Power Doppler Signal: areas of hypertrophic synovium were scanned A pulse
repetition frequency of 1000-1300Hz with a medium wall filter was used and
the gain was adjusted so the background signal was removed. Increased
signal was observed in both longitudinal and transverse planes and was
scored using a semi-quantitative system grade 0-3, (0=absent, 1=mild, 2=
moderate,3= marked or severe)7.
Intra-observer reliability for US measures was tested by performing a second scan
within 1 week on 28 knees by the same assessor (MH). Intra-class correlation co-
efficients (ICC) were calculated for continuous measures of effusion 0.93 (95% CI,
0.75-0.98), synovial hypertrophy 0.89 (95% CI, 0.64-0.97) and popliteal cysts 0.79
9(95% CI, 0.61-0.90). Intra-observer reliability for PDS was evaluated using a
weighted kappa and was statistically perfect, kappa = 1.0 (p<0.001), but will have
been influence by the low occurrence of PDS.
Statistical analysis
Our primary analysis was to compare the differences between groups. Analyses
were carried out on data for the index knee (the most symptomatic, or randomly
chosen knee) using IBM SPSS Statistics 19. All analyses were tested at the
significance level p<0.05. For nominal or frequency data the Chi-square test was
used, Fisher’s exact test was reported where the expected frequencies were less
than 5. Post-hoc comparisons were made using the z-test with adjusted p values
(the Bonferroni method was used when making multiple paired comparisons to
control for Type I error rates). The distributions of continuous variables were tested
using the Kolmogorov-Smirnov test. Differences between groups were then
compared using the one-way ANOVA and post-hoc Bonferroni tests for normally
distributed data and the Kruskal-Wallis test and post-hoc Mann Whitney tests with a
Bonferroni correction for non-normally distributed data.
Secondary analysis examined the relationships between continuous US measures,
pain VAS scores and radiographic severity (Nottingham LDA scores) using
Pearson’s correlation coefficients or Spearman's rho. Change in pain VAS scores
and US measures at 3 month follow-up was examined using a paired t-test or
Wilcoxon Signed Ranks Test, and correlation analysis was used to examine
relationships between change in pain severity and change in US measures.
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Results
Characteristics of study groups
Baseline assessments were performed on 243 participants, 65% were women, mean
age was 70 years and BMI was 28.1 kg/m2. The four study groups were made up of
90 controls, 59 KP, 32 ROA, and 62 SROA participants. Recruited participants were
representative of their original studies in terms of age though more females than
males were recruited. Final recruitment to each group was unbalanced, with the
ROA group under represented and SOA group over represented in the final analysis.
Baseline characteristics for each group are presented in table I. The gender
distribution between each group was similar but the KP group was younger (p<0.05)
and the control group had a lower BMI (p<0.05) compared to other groups. Pain
variables did not differ between the KP and SROA groups. Radiographic severity
(LDA scores) were higher in the SROA group compared to ROA group (p=0.05).
Clinical effusions were rare among controls (2.2%) and KP participants (3.4%) but
were more common in ROA (15.6%) (p<0.05) and again in SROA (50%), (p=0.05).
Morning stiffness ≥ 30 minutes duration was exclusively reported by those with pain.  
US findings at baseline
Table II summarises the US findings for each group. We found no difference in the
frequency or severity of US features between control and KP participants. Effusions,
synovial hypertrophy and popliteal cysts were more frequently observed in the ROA
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and SROA groups compared to KP and control groups (p<0.05) (figure I). Synovial
hypertrophy was more common again in the SROA compared to ROA group
(p<0.05). The frequency of popliteal cysts increased in ROA (21.9%, p<0.05) and
SROA (39%, p<0.05) groups compared to controls but were not different to each
other. PD signal was more frequently observed in of SROA participants (16%) than
control (2%, p<0.05) and KP (3%, p<0.05) groups. Grade of PD signal was not
subject to analysis due to the low frequency observed. Infra-patellar bursae and pes-
anserine bursae were rare and did not differ between groups.
Continuous measures of effusions and synovial hypertrophy were greater in ROA
(mean depth (SD) = 6.0mm (2.8) and 3.9mm (3.9) respectively) compared to controls
and KP groups (p<0.05), and were greater again in the SROA group (mean depth
(SD) = 8.1mm (4.0) and 6.7mm (3.3), p<0.05 respectively) (figure II).
Relationships between US features, pain and radiographic severity
We found moderate correlations between radiographic scores derived from the LDA
atlas and direct US measures of effusion and synovial hypertrophy (r= 0.6 and r=0.7
r=0.3 respectively, p≤ 0.01) (table III). Correlations between pain VAS scores and US 
measures were weak but significant for effusion (r= 0.3, p<0.01) and synovial
hypertrophy (r= 0.3, p<0.01) (table III). The strength of the correlation was similar for
pain assessed using the VAS, WOMAC and ICOAP scores.
Change in pain and US measures at 3 months
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At 3 months, follow-up assessments for pain and US measures were carried out in
45 (72.5%) of SROA participants and 57 (63%) of controls (table IV). Pain VAS
scores and US measures did not change within the control group. In the SROA
group, there was a statistically significant reduction in mean depth of synovial
hypertrophy (mean difference= -1.4mm SD (3.0), p=0.003) after 3 months but there
was no change in mean effusion, popliteal cyst measures or pain measures. We
found no correlation between change in pain and change in US measures for either
group (data not shown) though a change in US effusion was strongly correlated with
a change in synovial hypertrophy that was statistically significant for both controls (r=
0.4, p<0.05) and SROA groups (r=0.6, p<0.01).
Discussion
This first community-based US study has confirmed that US features are more
common in those with radiographic OA compared to those without and that severity
of effusion and synovial hypertrophy are greater in those with painful OA. We found
that direct measures of US features were moderately correlated with radiographic
severity but had a weaker relationship with pain severity. Over a 3 month-period,
SROA participants showed a reduction in mean synovial hypertrophy but there was
no parallel reduction in knee pain suggesting that, in the community at least, US
features accompany structural changes of knee OA but do not readily explain the
severity of pain.
Previous studies have shown grey-scale US features to be common in SROA though
prevalence rates vary between 33-86% for effusion8, 31 17-93% for synovial
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hypertrophy5, 8 and 6-43% for popliteal cysts7, 8. Our frequency data are higher than
some studies which may be attributable to variations in scanning protocols. We
included the medial and lateral recesses of the supra-patellar pouch and joint lines
when scanning and our findings are more comparable with those who scanned the
joint widely8. PD signal is frequently cited as a surrogate for active synovitis but is
not commonly reported in US studies of knee OA6, 32, 33. Our study is one of only a
few that has reported using PDS and though we found it more frequently in SROA
participants (16%, p<0.05) compared to all other groups the severity was graded as
only mild-moderate.
Few studies have directly investigated the relationship between radiographic severity
and US features in knee OA. D’agostino et al reported the presence of greyscale US
features was associated with higher radiological scores (K&L grade 3–4)5, and MRI
studies have also reported a significant relationship between synovial hypertrophy
and radiographic severity34. Using the Nottingham LDA we were able to correlate
direct measures of US features with ordinal radiographic scores. We found moderate
correlations between radiographic severity and US measures of synovial hypertrophy
and effusion, which to us suggests that direct and indirect changes of the synovium
are a reflection of the overall structural damage and reparative attempts of the
osteoarthritic joint.
Previous conclusions on the relationship between US features and pain is knee OA
are inconsistent. De Miguel et al reported US effusion to increase the risk of knee
pain by 6.5 times and Baker’s cysts by 5.5 times but found no association between
US features and pain severity10. Others have reported positive associations between
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US effusion with higher pain VAS scores on motion and at rest 9, 35. However, two
recent cross-sectional studies reported no association between US features and
either the presence of knee pain or pain severity6,20. We examined correlations
between different pain measures (pain VAS, WOMAC, ICOAP intermittent and
constant subscales) and direct measures of greyscale features and found that both
effusions and synovial hypertrophy were both correlated with pain severity but only
modestly so. There was also no difference between the strength of the relationship
for intermittent knee pain and constant knee pain, which may be thought of as more
mechanical and inflammatory type pain, respectively. Little has been reported on the
temporal changes of US features relative to change in knee pain. MRI studies have
shown that while an increase in synovitis correlates modestly with increased pain
severity or more frequent pain, a reciprocal decrease is not observed when pain
decreases36, 37. We found that in SROA participants mean measures of synovial
hypertrophy decreased over a 3 month period but this was not accompanied by a
parallel reduction in pain severity.
This suggests that perhaps synovial hypertrophy as observed on grey-scale US is
not as “inflammatory” as we would like to believe. Previous studies have shown that
grey-scale US cannot differentiate between synovial hypertrophy and synovitis,
tissue debris and fibrosis are known to mimic some US features of synovial
proliferation but these features do not exhibit PD signal 38-40. We found hypertrophy
to be common but PD signal much less so. This raises the question that if effusion
and synovial hypertrophy detected by US are not “inflammatory” in nature then what
do they represent? The reduction in lymphatic vessels that occurs in knee OA
synovium could cause increased synovial thickening and effusion through altered
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dynamics of fluid drainage rather than from “inflammation”41, and it has been
suggested that altered joint biomechanics may permanently modify the baseline
volume of synovial fluid42. In knee OA, the precipitating event is almost always
mechanical in nature resulting either from acute injury, repetitive micro-trauma,
increased focal stresses from abnormal anatomy or a combination thereof 11.
Capsular tissues are dynamic in terms of synthesis and orientation and respond to
the biomechanical forces acting on them. Importantly, synovial thickening is localised
rather than diffuse in OA and this may be reflective of damage in the adjacent areas
of cartilage, bone or entheses but may also represent a cellular response to
biomechanical stresses within the joint capsule. Different patterns of synovial
thickening on US and MRI have been identified but whether they are associated with
joint biomechanics has not yet been investigated 8, 43, 44. It seems likely from our data
that effusion and synovial hypertrophy mainly reflect the overall changes that occur
in knee OA.
There are some caveats to this study. Firstly, recruitment to the study was not
random; participants were purposefully recruited to each study group with the aim of
comparing four groups with a balanced number of 50 participants. Participants were
drawn from previous community studies of knee pain for whom a variable amount of
time (between 3 and 10 years) had passed between participation in the original and
current study23-25. As such, previous radiographic and pain status may have changed
for some potential participants i.e. there would an incidence of new radiographic OA
and new knee pain, as well as knee pain having resolved in others. The prevalence
of asymptomatic ROA lies between 27-44% of the general population45 but
identifying those participants is inherently difficult as they are asymptomatic and
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require radiographs to confirm their status. Consequently, recruitment to each group
was unbalanced, with the ROA group under represented and SOA group over
represented in the final analysis. Secondly, the study design was primarily intended
for the comparison of the 4 study groups. Secondary analyses examining the
relationships between pain, structural change and US features were derived from the
4 different groups and the correlations may not be representative of the general
population. Thirdly, the population for this study was drawn from the community and
differences in population demographics limits direct comparisons with hospital-based
US studies where SROA participants are often younger, with less severe
radiographic changes but higher levels of reported pain5. Comparisons may also be
limited by variations in definitions of US pathology and scanning protocols which vary
between studies. Finally, issues around defining knee pain and knee OA are well
documented46-49. We chose our defining criteria as it enabled all participants to be
allocated to a group. As a consequence the comparison groups are not completely
distinct, that is some control/ROA participants had mild symptoms and some
control/KP participants had minor structural change (K&L grade1).
In conclusion, this study highlights the correlation between greyscale US features
and radiographic severity. However, it questions the general assumption that
synovial abnormalities are “inflammatory” in nature and is responsible for driving pain
in OA, and suggests instead that they are a part of the overall structural pathology
reflecting the biomechanical adaptations of the OA joint. PD signal which is widely
asserted to represent a more “active inflammation” was more common in painful OA
compared to controls but did not differ significantly from asymptomatic OA but this
may not be the case for hospital referred patients. US features, particularly synovial
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hypertrophy, may well have a role to play in the development of painful OA but given
the multi-factorial nature of pain this is unlikely to be straight forward. Further
longitudinal studies are required to demonstrate whether US features are important
in the development and progression of structural change and symptoms.
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Table I Clinical characteristics of each group
Characteristics Controls
(N=90)
KP
(N=59)
ROA
(N=32)
SROA
(N=62)
P
Age (years) mean (SD) 71 (7.9) 63.8 (8.8)** 73.1 (7.9) 73.9 (7.8) <0.001
BMI (kg/m2) mean (SD) 26.5 (4.4)** 28.5 (4.0) 29.6 (5.3) 29.2 (4.1) =0.001
Women n (%) 63 (70%) 33 (55.9%) 19 (59.3%) 42 (67.7%) =0.29
Nottingham LDA scores
Global Score (0-60) mean (SD) 1.1 (1.5) 0.5 (1.1) 11.9 (7.1)* 17.5 (8.0)** <0.001
Pain characteristics
Pain VAS (mm) mean (SD) 6.6 (11.0) 48.9 (22.0)* 7.2 (14.4) 48.2 (24.6)* <0.001
WOMAC Pain (0-20) mean (SD) 1.0 (1.51) 8.0 (3.34)* 0.9 (1.34) 8.1 (3.23)* <0.001
ICOAP Subscales
Constant (0-20) mean (SD) 0.5 (1.2) 5.9 (4.8)* 0.2 (.59) 6.9 (5.2)** <0.001
Intermittent (0-24) mean (SD) 1.6 (2.5) 10.2 (4.1)* 2.0 (3.1) 10.6 (5.5)** <0.001
Clinical
Clinical effusion n (%) 2 (2.2%) 2 (3.4%) 5 (15.6%)* 31 (50%)** <0.001
EMS ≥30 mins                           n (%) 0 (0%) 20 (37.7%)* 0 (0%) 15 (27.3%)* <0.001
WOMAC Stiffness (0-8) mean (SD) 0.8 (1.1) 3.4 (1.6)* 0.9 (0.9) 4.0 (1.8)* <0.001
WOMAC Function (0-68) mean (SD) 4.2 (6.5) 25.8 (12.3)* 5.5 (6.6) 29.6 (11.8)* <0.001
P value represents significant difference between the 4 groups using Χ2 tests for frequency data and one-way ANOVA for
continuous data.
*group differs significantly from control p<0.05 after applying post-hoc Bonferroni test
** group differs significantly from all groups p<0.05 after applying post-hoc Bonferroni test
KP, knee pain only; ROA, radiographic OA; SOA, symptomatic OA; BMI, Body Mass Index; LDA, line drawing atlas; WOMAC,
Western Ontario and MacMasters Index; ICOAP, Intermittent and Constant Osteoarthritis Pain questionnaire; EMS ≥30 mins, a 
dichotomous variable was created for EMS (early morning stiffness) lasting longer than 30 minutes.
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Table II Frequency and severity of Ultrasound (US) features
US Features
Controls
(n=90)
KP
(n=59)
ROA
(n=32)
SROA
(n=62)
p
Effusion n (%) 26 (28.9) 19 (32.2) 26 (81.3)* 57 (91.9)* <0.001
Synovial hypertrophy n (%) 7 (7.8) 7 (11.9) 13 (40.6)* 51 (82.3)** <0.001
Popliteal cysts n (%) 11 (12.4) 5 (8.6) 7 (21.9)* 23 (39.2)* <0.001
Infra-pat bursitis n (%) 3 (3.3) 4 (6.8) 0 (0) 5 (8.1) 0.28
Pes-Anserine Bursitis n (%) 0 (0) 0 (0) 0 (0) 4 (6.5) ns
Power doppler signal n (%) 2 (2.2) 2 (3.4) 2 (6.3) 10 (16.2)* =0.005
Grade 1 n (%) 2 (2.2) 1 (1.7) 2 (6.3) 5 (8.1)
Grade 2 n (%) 0 (0) 0 (0 ) 0 (0) 5 (8.1)
Grade 3 n (%) 0 (0) 1 (1.7) 0 (0) 0 (0)
Continuous US features
Effusion (mm) mean (SD) 2.6 (2.7) 3.4 (3.2) 6.0 (2.8)* 8.1 (4.0)** <0.001
Synovial Hypertrophy mean (SD) 0.7 (1.5) 1.0 (1.9) 3.9 (3.9)* 6.7 (3.3)** <0.001
Popliteal cysts (mm) mean (SD) 1.0 (2.6) 0.8 (2.2) 1.8 (3.6) 3.5 (4.7)* =0.001
P value represents significant difference between the 4 groups using Χ2 tests for frequency data and one-way ANOVA for
continuous data.
*differs significantly from control and KP group p<0.05
**differs significantly from all groups p<0.05
US, Ultrasound; KP, knee pain only; ROA, radiographic OA; SROA, symptomatic OA; BMI, Body Mass Index;
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Table III Correlations between continuous US measures, pain severity and
radiographic severity
** Correlation is significant at the 0.01 level
mm, millimeters; VAS, visual analogue scale; WOMAC, Western Ontario and MacMasters Index;
ICOAP, Intermittent and Constant Osteoarthritis Pain questionnaire; LDA, Line Drawing Atlas
Effusio
n
(mm)
Synovial Hypertrophy
(mm)
Popliteal cyst
(mm)
Pain VAS (mm) 0.3** 0.3** 0.1
WOMAC pain subscale 0.3** 0.3** 0.1
ICOAP Intermittent subscale 0.3** 0.3** 0.1
ICOAP Constant subscale 0.3** 0.3** 0.1
Radiographic severity -
Nottingham LDA score (0-60) 0.6** 0.7** 0.3**
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Table IV Pain and US measures in control and SROA participants at baseline and 3
months
Controls
N=57
SROA
N=45
Baseline 3 months p Baseline 3 months p
Pain VAS (mm) 3.1 (5.6) 5.8 (13.6) 0.33 52.5 (23.0) 54.0 (25.5) 0.65
Effusion (mm) 2.3 (2.4) 2.2 (2.4) 0.80 8.6 (4.6) 8.6 (4.9) 0.96
Synovial Hypertrophy (mm) 0.6 (1.5) 0.7 (1.9) 0.67 7.1 (4.0) 5.7 (4.3) 0.003*
Popliteal cysts (mm) Median (range) 0 (0-11.6) 0 (0-12.4) 0.53 0 (0-14.3) 1.15 (0.13.4) 0.45
Data represent mean (SD ) unless stated.
P value represents significant difference between the baseline and 3 months using paired t test for normally distributed and
Wilcoxon signed rank test for non-normally distributed data. * diferrence is significant at <0.05
SROA, symptomatic OA; BMI, Body Mass Index; mm, millimeters
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Figure I Bar chart showing frequency (%) of US features within each
comparison group.
Figure II US measures of (A) effusion and (B) synovial hypertrophy for each
group.
